EAVI2020 EAVI2020 on Twitter EAVI2020 on LinkedIn

BioNTech RNA Pharmaceuticals GmbH

BioNTech RNA Pharmaceuticals GmbH is a technology leader in the field of synthetic mRNA therapeutics. Its system is based on the precise delivery of potent, long-lived synthetic mRNA into target cells. We aim to take advantage of the full potential of mRNA therapies including cancer immunotherapies, protein replacement therapies and stem cell engineering, as well as infectious disease vaccines.

BioNTech will provide novel, highly immunogenic, prophylactic and therapeutic vaccine candidates. These vaccines are based on BioNTech´s self-amplifying RNA vaccine vector technology which is ideal for expressing high levels of HIV antigens in vaccine recipients.


Dr. Annette Vogel


Dr. Karen Nieto